Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol
February 08, 2024 08:00 ET
|
Lophos Holdings Inc.
NAPANEE, Ontario, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned...